Pharyngeal Squamous Cell Carcinoma — Trials

Pharyngeal Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

297 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 106
Recruiting: 52
Ph III recruiting: 3
Growth YoY: −15%
Industry share: 8%
Top sponsor: National Cancer Institute (NCI)
Termination share: 41.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (51)

clinicaltrialsPublishedShowing 51–66 of 66 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07343271	Dual-energy CT vs. MRI in the Evaluation of Squamous Cell Carcinomas of the Oral Cavity and Oropharynx(DECT-CEco)	recruiting	—	30	University Hospital, Strasbourg, FranceOTHER	1	Jan 15, 2026	clinicaltrials
NCT03215719	Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma	recruiting	Phase 2	120	NYU Langone HealthOTHER	1	Jan 6, 2026